Bill Would Cap Cannabis Concentrates Potency at 30% in Washington

A bipartisan proposal being considered in Washington state would cap the potency of cannabis concentrates at 30% THC and raise the minimum age for purchasing extracts to 25 years old.

Full story after the jump.

For the second year in a row, a bill has emerged in Washington state aimed at limiting the potency of cannabis concentrate products. The bill, HB 1463, has bi-partisan sponsors and is scheduled for a hearing on February 12 in the Washington House. The legislation cites health concerns around “high potency” cannabis and includes a recent consensus statement from a group of Washington State University and University of Washington cannabis researchers.

“Use of cannabis with high THC concentration increases the chances of developing cannabis use disorder or addiction to cannabis, particularly among adolescents. High-potency cannabis use can have lifelong mental health consequences, which often manifest in adolescence or early adulthood. Daily cannabis use, particularly of high-potency products, increases the risk of developing a psychotic disorder, like schizophrenia, and is related to an earlier onset of symptoms compared to people who do not use cannabis.” — Consensus statement excerpt

If passed, the bill would limit cannabis concentrates to 30 percent THC and raise the age of purchase to 25. An exemption would be made for registered medical cannabis patients.

Bo Jackson, a Washington cannabis consumer who lobbied last year against a similar bill, said he is organizing to push back on this year’s attempt.

“This will incentivize black market sales, as cannabis concentrates of more than 30% are popular and sought by consumers,” he told Ganjapreneur. “The age restriction, 25 for concentrates, is inconsistent with current regulations we see on tobacco and alcohol and seems to be targeting cannabis consumers. While every industry is subject to regulation, those regulations need to benefit the entire community. This bill creates an arbitrary restriction that hurts consumers, industry, and medical users.”

Get daily cannabis business news updates. Subscribe

Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.


Latest Cannabis News

View all news Get email updates

Create a profile View all categories

From Our Partners